NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/19/2023
Back to search
Official data from USPTO
TSCAN THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
12/19/2023
Trademark type
Combined
Nice classes
5, 42
Filing date
11/21/2022
Registration date
12/19/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/19/2023
Last transaction
12/19/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/09/2023
First use in commerce
03/09/2023
Drawing code
3
Owner type
03
Owner location
Waltham, MA, US
Examiner
PRIZANT, JAMES
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the term "TSCAN THERAPEUTICS", with "TSCAN" in large, capitalized sans-serif letters and "THERAPEUTICS" in small capitalized sans-serif typeface underneath. The "T" of TSCAN is depicted in negative or contrasting space within a shaded hexagon.
Holders and representatives
Holders
TScan Therapeutics, Inc.
Representatives
Joshua S. Jarvis, Esq. FOLEY HOAG LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of cancerautoimmune diseases and disordersinflammatory diseases and disorders
Class 42
Pharmaceutical research and development
Publications
History of USPTO decisions and trademark events.
28 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/19/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/11/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/10/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/19/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/18/2023
EX1G
SOU EXTENSION 1 GRANTED
09/18/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/18/2023
IUAF
USE AMENDMENT FILED
09/07/2023
EXT1
SOU EXTENSION 1 FILED
09/07/2023
EEXT
SOU TEAS EXTENSION RECEIVED
09/07/2023
EISU
TEAS STATEMENT OF USE RECEIVED
09/07/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/18/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/18/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/18/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/09/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/14/2023
PUBO
PUBLISHED FOR OPPOSITION
03/14/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/22/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/03/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
02/03/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/03/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
02/03/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/03/2023
DOCK
ASSIGNED TO EXAMINER
02/02/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/14/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/13/2022
NWAP
NEW APPLICATION ENTERED
11/24/2022
Continuous trademark protection
Get notified about every new filing that threatens TSCAN THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.